Navigation Links
Accuray Incorporated to Report Financial Results for Third Quarter Fiscal Year 2009

SUNNYVALE, Calif., April 13 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter fiscal year 2009, ending March 28, 2009 on Tuesday, May 5, 2009 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PDT/ 5:00 p.m. EDT and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer.

The conference call dial-in numbers are 1-866-379-2019 (USA) or 1-706-634-1525 (International), Conference ID: 90985949. In addition, a dial-up replay of the conference call will be available beginning May 5, 2009 at 5:00 p.m. PDT/8:00 p.m. EDT and ending on May 8, 2009. The replay telephone number is 1-800-642-1687 (USA) or 1-706-645-9291 (International), Conference ID: 90985949

A live webcast of the call will also be available from the Investor Relations section of the corporate Web site at A webcast replay can be accessed on the corporate Web site beginning Tuesday, May 5, 2009 at approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will remain available until Accuray announces its results for the fourth quarter of fiscal 2009, ending June 27, 2009.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 60,000 patients worldwide and currently more than 155 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accuray Announces Results for Second Quarter of Fiscal 2009
2. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
3. Accuray Incorporated to Present at 11th Annual Needham Growth Stock Conference
4. Accuray Hires Chief Financial Officer
5. Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care Conference
6. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
7. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
8. Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
9. Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results
10. Accuray Incorporated Announces Resignation of Chief Financial Officer
11. Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: